PF4 and kidney disorder: Urinary vascular cell adhesion molecule-1 (VCAM1), platelet factor-4 (PF4), and the best-performing activated leukocyte CAM (ALCAM) were recently demonstrated as potential biomarkers of kidney disease activity in a cSLE cohort [196].